TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
FTH

Faeth Therapeutics, Inc.

Healthcare · Biotechnology

10.00$ -5.8% vs. previous close Closing price · As of: Nov 13, 2026

Statements

Balance Sheet

Faeth Therapeutics, Inc. (FTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 179 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FTH
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26
74 67 60 53 45 38 32 28 23 205 189 179
67 60 54 48 42 36 30 26 22 204 189 178
13 11 12 19 10.0 9.9 13 11 8.7 152 27 14
66 58 52 47 41 34 29 25 21 203 186 175
9.5 8.2 7.6 7.5 7.0 6.3 4.5 4.6 4.3 14 16 11
5.6 5.0 4.9 5.4 5.4 5.2 3.9 4.4 4.3 14 9.6 11
2.4 2.5 2.5 2.4 2.3 2.2 2.0 1.9 1.5 1.0 0.6 0.1
1.7 2.0 1.6 1.7 0.2 0.4 0.4 0.3 0.7 3.4 2.1 3.0
65 58 52 46 38 32 27 23 19 191 173 168
-232 -240 -247 -254 -262 -269 -274 -278 -283 -453 -469 -490
1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 5.6 26

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?